Floatz logo

4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE

Early Mild Cognitive Impairment (EMCI)

University of Southern CaliforniaSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Early Mild Cognitive Impairment (EMCI) cohort.

Asset / SponsorPhaseRating
FLORTAUCIPIR
University of Southern California
D

Same molecule, other indications

4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE is also rated in:

Alzheimer diseaseDormant
BBB
Indicative ·
78 / 100
View asset →
Cardiac AmyloidosisDormant
BB
Indicative ·
68 / 100
View asset →
cognitive disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →